SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
295.80    10.40 (3.64%)
Bid:
296.80
Ask:
297.40
Spread: 0.60 (0.202%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Trading Update

20 Nov 2019 07:00

RNS Number : 9723T
Breedon Group PLC
20 November 2019
 

 

NEWS RELEASE 

20 November 2019

 

BREEDON GROUP PLC ("Breedon" or "the Group")

Trading Update

 

Trading performance

 

Breedon delivered a strong performance in the 10 months to 31 October 2019, with increased revenues, improved underlying EBIT and continuing robust cash generation, including a 10-month contribution from the former Lagan Group ("Lagan"), acquired in April 2018.

 

These results were achieved against the backdrop of a flat construction market in Great Britain ("GB"), where lower industry sales volumes were recorded for all major heavyside construction materials in the nine months to 30 September 2019.

 

Group sales volumes of aggregates increased by four per cent, asphalt by eight per cent and cement by six per cent, while ready-mixed concrete volumes declined by five per cent. As a result, Group revenues grew by eight per cent to approximately £800 million.

 

The integration of Lagan is now largely complete and we remain confident of delivering the anticipated annual cost synergies. Roadway Civil Engineering & Surfacing Ltd, acquired on 1 October, is performing as expected.

 

Assuming no materially adverse weather conditions for the remainder of the year, the Group's Underlying EBIT for the full year is expected to be in line with current market expectations1.

Outlook

 

Breedon continues to be a well-invested business, with capital expenditure maintained in line with depreciation, which is enabling us to continue to enhance our operational performance and improve our productivity. Our cash generation is allowing us not only to maintain this high level of investment, but also quickly to pay down our borrowings, and we expect year-end leverage to fall further to approximately 1.5 times underlying EBITDA on a pre-IFRS 16 basis.

 

Looking ahead, while the upcoming General Election and ongoing Brexit negotiations create near-term uncertainty, the longer-term outlook for our markets remains encouraging with forecasters expecting GB construction to grow modestly in 2020 whilst Ireland is expected to see further double digit growth. Furthermore, we have consistently proved that we can produce superior results irrespective of market conditions. Our focus on driving organic improvement, together with a healthy acquisition pipeline, gives us confidence that we will make further progress in 2020.

 

We will announce our preliminary results for the year ending 31 December 2019 on 11 March 2020.

 

1 The Group believes that current market expectations for Underlying EBIT range from £114 million to £118 million. 

 

Note to editors

 

Breedon Group plc is a leading construction materials group in Great Britain and Ireland. It operates two cement plants and an extensive network of quarries, asphalt plants and ready-mixed concrete plants, together with slate production, concrete and clay products manufacturing, contract surfacing and highway maintenance operations. The Group employs nearly 3,000 people and has nearly 900 million tonnes of mineral reserves and resources. Its strategy is to continue growing organically and through the acquisition of businesses in the heavyside construction materials market.

 

For further information:

 

Breedon Group plc

Pat Ward, Group Chief Executive

Rob Wood, Group Finance Director 01332 694010

 

Stephen Jacobs, Group Head of Communications 07831 764592

 

Cenkos Securities (NOMAD and Joint Broker)

Max Hartley/Harry Hargreaves 020 7397 8900

 

Numis (Joint Broker)

Ben Stoop/Heraclis Economides 020 7260 1000

 

Teneo

Matt Denham/ Rachel Miller 020 7420 3180

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUKSWRKAAAAAA
Date   Source Headline
10th Jul 20197:00 amRNSHolding(s) in Company
9th Jul 20192:57 pmRNSHolding(s) in Company
7th Jun 20194:44 pmRNSHolding(s) in Company
7th Jun 20199:00 amRNSHolding(s) in Company
4th Jun 20191:01 pmRNSDirector / PDMR Dealings & Total Voting Rights
29th May 201912:38 pmRNSFurther re: Intended Sale of Shares
29th May 20197:05 amRNSIntended Sale of Shares
29th May 20197:00 amRNSDirectorate Change
7th May 20195:05 pmRNSDirector / PDMR Dealings & Total Voting Rights
30th Apr 20192:39 pmRNSResult of AGM
30th Apr 20197:00 amRNSAGM Statement
16th Apr 201910:14 amRNSDirectors' and PDMRs' Dealings
8th Apr 20193:12 pmRNSDirector and PDMR Dealings & Issue of Equity
2nd Apr 201912:02 pmRNSDirector and PDMR Dealings and Issue of Equity
1st Apr 20195:00 pmRNSGrant of SAYE Options and PDMR Dealings
18th Mar 20199:23 amRNSDirector Dealings
6th Mar 20197:00 amRNSAnnual Results 2018
15th Feb 201910:53 amRNSHolding(s) in Company
23rd Jan 20192:30 pmRNSBlock listing Interim Review
18th Dec 201811:20 amRNSDirectorate Change
17th Dec 201810:20 amRNSDirector/PDMR Shareholding
14th Dec 20183:46 pmRNSDirector/PDMR Shareholding
12th Dec 20182:27 pmRNSDirector/PDMR Shareholding
7th Dec 20181:00 pmRNSDirector/PDMR Shareholding
6th Dec 20184:57 pmRNSDirector/PDMR Shareholding
27th Nov 201812:00 pmRNSTotal Voting Rights
21st Nov 20187:00 amRNSTrading Update
23rd Oct 20183:55 pmRNSDirector/PDMR Shareholding
17th Oct 20184:42 pmRNSDirector/PDMR Shareholding
16th Oct 20185:00 pmRNSGrant of SAYE Options and PDMR Dealings
12th Oct 201810:00 amRNSDirector/PDMR Shareholding
1st Oct 20188:05 amRNSAppointment of Non-Executive Director
25th Sep 20184:17 pmRNSDirector/PDMR Shareholding
14th Sep 20183:21 pmRNSHolding(s) in Company
14th Sep 20183:20 pmRNSHolding(s) in Company
5th Sep 20187:01 amRNSAppointment of Non-Executive Director
5th Sep 20187:00 amRNSHalf-year Report
1st Aug 20183:57 pmRNSHolding(s) in Company
25th Jul 20182:58 pmRNSHolding(s) in Company
25th Jul 20187:00 amRNSBlock Listing Update
2nd Jul 20187:00 amRNSBREEDON COMPLETES ASSET SWAP WITH TARMAC
1st Jun 20185:30 pmRNSDirector/PDMR Shareholding
1st Jun 20187:00 amRNSAcquisition of Blinkbonny Quarry
17th May 20184:55 pmRNSGrant of SAYE Options and PDMR Dealings
11th May 20183:30 pmRNSResults of Open Offer
8th May 201812:49 pmRNSDirector and PDMR Dealings
30th Apr 20184:19 pmRNSDirector/PDMR Shareholding
27th Apr 20182:18 pmRNSAdditional Block Listing of Ordinary Shares
26th Apr 20181:29 pmRNSDirector and PDMR Dealings and Issue of Equity
26th Apr 20188:00 amRNSCMA's Review of Proposed Acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.